Literature DB >> 16272397

Evaluation of O-antigen inactivation on Pla activity and virulence of Yersinia pseudotuberculosis harbouring the pPla plasmid.

Flavie Pouillot1, Anne Derbise, Maini Kukkonen, Jeannine Foulon, Timo K Korhonen, Elisabeth Carniel.   

Abstract

Yersinia pestis is a species that emerged recently from Yersinia pseudotuberculosis and gained an exceptional pathogenicity potential. Among the major genetic differences between the plague bacillus and its ancestor is the acquisition of the pPla plasmid, which has been associated with the increased virulence of Y. pestis. In a previous study, introduction of pPla into Y. pseudotuberculosis did not lead to any modification of the virulence of the host bacterium. However, it was subsequently demonstrated that the presence of smooth lipopolysaccharide (LPS) inhibits the activity of Pla. In this study, pPla was introduced into a Y. pseudotuberculosis strain expressing smooth LPS, and into a variant in which a mutation that abrogates the formation of O-antigen (O-Ag) repeats (as in natural isolates of Y. pestis) was generated. It was found that in both strains, Pla was synthesized, exported to the bacterial membrane and processed as in Y. pestis. However, the ability of Pla to activate plasminogen was weak and observed only at 37 degrees C in the smooth strain, while this activity was similar to that of Y. pestis and expressed at both 28 and 37 degrees C in the O-Ag mutant strain. Similarly, Pla-mediated inactivation of the antiprotease alpha2-antiplasmin was not detected in the smooth Y. pseudotuberculosis strain grown at 28 degrees C, but was expressed at both temperatures in the O-Ag mutant strain. Despite the more efficient activity of Pla, the Y. pseudotuberculosis O-Ag mutant strain exhibited a lower pathogenicity upon subcutaneous infection of mice. The results thus indicate that, although abrogation of O side chain synthesis in a Y. pseudotuberculosis strain harbouring pPla potentiates the two proteolytic activities of Pla, this is not sufficient to confer to Y. pseudotuberculosis a higher pathogenicity potential. These results also suggest that acquisition of pPla may not have been sufficient to confer an immediate higher pathogenic potential to the ancestor Y. pestis strain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16272397     DOI: 10.1099/mic.0.28274-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  21 in total

1.  ICEEc2, a new integrative and conjugative element belonging to the pKLC102/PAGI-2 family, identified in Escherichia coli strain BEN374.

Authors:  David Roche; Maud Fléchard; Nathalie Lallier; Maryline Répérant; Annie Brée; Géraldine Pascal; Catherine Schouler; Pierre Germon
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

2.  A multi-omic systems approach to elucidating Yersinia virulence mechanisms.

Authors:  Charles Ansong; Alexandra C Schrimpe-Rutledge; Hugh D Mitchell; Sadhana Chauhan; Marcus B Jones; Young-Mo Kim; Kathleen McAteer; Brooke L Deatherage Kaiser; Jennifer L Dubois; Heather M Brewer; Bryan C Frank; Jason E McDermott; Thomas O Metz; Scott N Peterson; Richard D Smith; Vladimir L Motin; Joshua N Adkins
Journal:  Mol Biosyst       Date:  2012-11-13

3.  Delineation and analysis of chromosomal regions specifying Yersinia pestis.

Authors:  Anne Derbise; Viviane Chenal-Francisque; Christèle Huon; Corinne Fayolle; Christian E Demeure; Béatrice Chane-Woon-Ming; Claudine Médigue; B Joseph Hinnebusch; Elisabeth Carniel
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

4.  Characterization of chromosomal regions conserved in Yersinia pseudotuberculosis and lost by Yersinia pestis.

Authors:  Flavie Pouillot; Corinne Fayolle; Elisabeth Carniel
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

5.  Lovastatin protects against experimental plague in mice.

Authors:  Saravanan Ayyadurai; Hubert Lepidi; Claude Nappez; Didier Raoult; Michel Drancourt
Journal:  PLoS One       Date:  2010-06-02       Impact factor: 3.240

6.  Rapid identification and typing of Yersinia pestis and other Yersinia species by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry.

Authors:  Saravanan Ayyadurai; Christophe Flaudrops; Didier Raoult; Michel Drancourt
Journal:  BMC Microbiol       Date:  2010-11-12       Impact factor: 3.605

7.  Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain.

Authors:  Thierry Blisnick; Patrick Ave; Michel Huerre; Elisabeth Carniel; Christian E Demeure
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

8.  Capsular antigen fraction 1 and Pla modulate the susceptibility of Yersinia pestis to pulmonary antimicrobial peptides such as cathelicidin.

Authors:  Estela M Galván; Melissa A S Lasaro; Dieter M Schifferli
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

9.  Direct transcriptional control of the plasminogen activator gene of Yersinia pestis by the cyclic AMP receptor protein.

Authors:  Tae-Jong Kim; Sadhana Chauhan; Vladimir L Motin; Ee-Been Goh; Michele M Igo; Glenn M Young
Journal:  J Bacteriol       Date:  2007-10-12       Impact factor: 3.490

10.  Lipopolysaccharide of Yersinia pestis, the Cause of Plague: Structure, Genetics, Biological Properties.

Authors:  Y A Knirel; A P Anisimov
Journal:  Acta Naturae       Date:  2012-07       Impact factor: 1.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.